Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...